Table 3.

Registered clinical trials evaluating maintenance therapies in MOGAD. Information per clinicaltrials.gov

Clinical trial	Treatment	Comparator	Inclusion criteria	Primary outcome
IDAR (NCT05545384)	Azathioprine or rituximab	No maintenance treatment	Following first attack	Annualized relapse rate at 24 months
MOGwAI (NCT05349006)	Azathioprine with steroid taper	Steroid taper	Following first attack	Time to first relapse
cosMOG (NCT05063162)	Rozanolixizumab	Placebo	Relapsing course with ≥l relapse in 12 months	Time to first relapse
METEROID(NCT05271409)	Satralizumab (allows concomitant azathioprine or mycophenolate mofetil)	Placebo	Relapsing course with ≥l relapse in 12 months or ≥2 relapses in 24 months	Time to first relapse